AMGEN INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.22 BRL | -1.87% |
|
-1.87% | +14.55% |
| 06-14 | Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto | DJ |
| 06-14 | Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGEN INC. | Other Pharmaceuticals | -1.87% | -1.87% | +14.55% | +45.89% | +130.52% | 163B | - | - | - |
- Stock Market
- Equities
- AMGN Stock
- AMGN34 Stock
- Charts Amgen Inc.
- Relative Strength Chart